KAM
IPXL
Krensavage Asset Management’s Impax Laboratories, Inc. IPXL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,032,187
| Closed | -$24.5M | – | 18 |
|
|
2016
Q3 | $24.5M | Buy |
1,032,187
+301,370
| +41% | +$7.14M | 8.84% | 4 |
|
|
2016
Q2 | $21.1M | Buy |
730,817
+142,935
| +24% | +$4.12M | 7.59% | 3 |
|
|
2016
Q1 | $18.8M | Buy |
587,882
+2,712
| +0.5% | +$86.8K | 6.75% | 6 |
|
|
2015
Q4 | $25M | Buy |
585,170
+54,295
| +10% | +$2.32M | 7.98% | 6 |
|
|
2015
Q3 | $18.7M | Buy |
530,875
+75,400
| +17% | +$2.66M | 6.77% | 6 |
|
|
2015
Q2 | $20.9M | Buy |
455,475
+44,531
| +11% | +$2.04M | 7.89% | 3 |
|
|
2015
Q1 | $19.3M | Sell |
410,944
-12,217
| -3% | -$573K | 8.77% | 2 |
|
|
2014
Q4 | $13.4M | Buy |
+423,161
| New | +$13.4M | 7.47% | 4 |
|